OslerMD is a new device from a San Diego, California company of the same name that was designed to provide a quick health checkup by simply placing four fingers on top of a few sensors. The device can be used in high traffic areas such as outpatient clinics, pharmacies, and schools, but also to be used at home by post-op patients and others needing a vigilant eye to watch over their vitals.
One simply places their fingers over the four electrodes on the base of the OslerMD to have six vital signs recorded within thirty seconds. The device doesn’t have its own display, but instead relies on a tablet or smartphone to display the readings and to interact with other devices. Additional devices can include a scale, a blood pressure cuff, or a glucometer, each connected to the system via Bluetooth. All the readings are compiled by the app (iOS and Android) to produce a comprehensive report based on various parameters measured. These can then be transferred to one’s medical team, as well as to family and any caretakers.
Doctors’ offices can use the system during check-ins and to make things transparent, the data can be routed to the default electronic medical records (EMR) used by the physician group. Because other device can be tied into the OslerMD, the company is thinking of eventually producing a health kiosk based on its device that can be integrated into various health facilities.
The system requires no calibration and the firm is currently looking at introducing cuffless blood pressure monitoring in the system. Because purely cuffless BP technology is yet to be clinically validated, the leaders of the firm we spoke to believe they will be able to offer a hybrid approach. This would involve using a standard BP pressure cuff to make an initial measurement and then use “pulse pressure” readings from the fingers that would be adjusted based on the cuffed reading.
All the actual calculations are performed on the cloud, outside the app, a feature that the company believes will make the regulatory path easier for them during software updates.
The device is yet to be available, and the firm is currently raising round A funding to have the money necessary to get through the FDA’s class 2 device clinical trial. So far the company performed an in-house trial similar to what the FDA would require, and has been satisfied with the accuracy of the OslerMD.
The final cost is expected to be between $200 and $250. The hardware is all complete and the software is in the final stages of being polished. We are looking forward to seeing this product pass through the regulatory hurdles and for us to try it out in the not too distant future.
Product page: OslerMD…